National Comprehensive Cancer Network



About NCCN

Adolescent and Young Adult Oncology Panel - Disclosures as of 11/27/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Millennium Pharmaceuticals, Inc.;
Agios;
Ambit;
Astellas;
Cyclacel;
Epizyme;
Lilly Pharmaceuticals;
Talon;
Pfizer Inc.

Amgen Inc.;
ARIAD Pharmaceuticals, Inc.;
ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

6/4/2014

Smita Bhatia, MD, MPH

None

None

None

None

5/26/2013

Virginia (Ginger) F. Borges, MD, MMSc

None

None

None

None

3/12/2014

Scott C. Borinstein, MD, PhD

None

None

None

Consultans, Luvera Law Firm;
Whitlow, Roberts, Houston, and Straub LLC

9/16/2014

Peter F. Coccia, MD

None

None

None

None

11/18/2014

Joseph Flynn, DO, MPH, FACP

None

None

None

None

10/11/2013

A. Lindsay Frazier, MD, ScM

None

None

None

None

10/21/2013

Robert Goldsby, MD

None

None

None

None

4/2/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Robert Hayashi, MD

None

National Childrens Cancer Society

None

None

4/1/2013

Mary S. Huang, MD

None

None

None

None

4/2/2014

Rebecca H. Johnson, MD

None

None

None

None

4/27/2012

Lynda Kwon Beaupin, MD

None

None

None

None

4/3/2014

Michael P. Link, MD

Novartis Pharmaceuticals Corporation;
Seattle Genetics

Jannsen Pharmaceutica Products, LP

None

None

3/10/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Fred Millard, MD

Bristol-Myers Squibb Company;
Dendreon Corporation;
Eli Lilly and Company;
Exelixis Inc.;
Altor, Inc;
Argos Therapeutics;
Moores UCSD Cancer Center;
sanofi-aventis U.S.

Ambrx, Inc

None

None

3/25/2014

Kevin C. Oeffinger, MD

None

None

None

None

3/25/2013

Kathleen M. Orr, MSW, LCSW-C

None

None

None

None

4/9/2014

Alberto S. Pappo, MD

None

;
Ziopharm

None

None

8/26/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

10/1/2014

Damon R. Reed, MD

None

None

None

None

8/15/2013

Kenneth Roberts, MD

None

None

None

None

11/20/2014

Steven Robinson, MBBS

None

None

None

None

9/25/2014

Dorothy Shead, MS

None

None

None

None

8/7/2014

Holly L. Spraker, MD, MS

None

None

None

None

12/26/2013

Hema Sundar, PhD

None

None

None

None

10/27/2014

Deborah A. Thomas, MD

None

Amgen Inc.;
Spectrum Pharmaceuticals

None

None

2/5/2014

Margaret von Mehren, MD

;
Eisai Inc.;
Johnson & Johnson;
Merck & Co., Inc.;
Morphotek Inc.;
National Cancer Institute;
Novartis Pharmaceuticals Corporation;
OSI Pharmaceuticals, Inc.;
Arog Pharmaceuticals;
Astex;
Sarcoma Alliance for Research through Collaboration;
Pfizer Inc.;
Synta Pharmaceuticals Corp.

Eisai Inc.;
Novartis Pharmaceuticals Corporation

None

None

9/1/2014

Daniel S. Wechsler, MD, PhD

None

Hyundai Hope on Wheels;
Jazz Pharmaceuticals;
Sigma-Tau Pharmaceuticals, Inc.

None

None

9/16/2014

Kimberly F. Whelan, MD

None

None

None

None

9/16/2014

Bradley J. Zebrack, PhD, MSW, MPH

None

Onyx Pharmaceuticals, Inc.

None

None

12/9/2013